The American Journal of Medicine
Volume 121, Issue 1 , Pages 10-12, January 2008

Chylomicronemia and the Chylomicronemia Syndrome: A Practical Approach to Management

  • David Alexander Leaf, MD, MPH

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to David Alexander Leaf, MD, MPH, Division of General Internal Medicine, 111G, Greater Los Angeles VA Healthcare System, Wilshire and Sawtelle Blvds, Los Angeles, CA 90073.

Departments of Medicine, UCLA School of Medicine and Greater Los Angeles VA Healthcare System, Los Angeles, California.

Abstract 

Chylomicronemia is present when triglyceride levels exceed 1000 mg/dL. Chylomicronemia, when accompanied by eruptive xanthoma, lipemia retinalis, or abdominal symptoms, is referred to as the “chylomicronemia syndrome” and can cause acute pancreatitis. Treatment aimed at reducing triglyceride levels includes lifestyle modifications to promote weight loss with diet and physical activity coupled with medications, including fibrates, n-3 polyunsaturated fatty acids, and nicotinic acid. Chylomicronemic patients with acute pancreatitis require insulinization in an inpatient setting to abolish chylomicronemia.

Keywords: Chylomicronemia, Lipids, Pancreatitis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9343(07)00987-4

doi:10.1016/j.amjmed.2007.10.004

The American Journal of Medicine
Volume 121, Issue 1 , Pages 10-12, January 2008